Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Postprandial prolactin suppression appears absent in antipsychotic-treated male patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Familial associations in hair cortisol concentration: A cross-sectional analysis based on the Healthy Start study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Characteristics influencing expected cognitive performance during hypoglycaemia in type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Neuroticism modulates mood responses to pharmacological sex hormone manipulation in healthy women

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma fibulin-1 levels during pregnancy and delivery: a longitudinal observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Weight gain on antipsychotics – A perfect storm of complex pathophysiology and psychopharmacology

    Research output: Contribution to journalLetterResearchpeer-review

  3. Exendin(9-39)NH2 - recommendations for clinical use based on a systematic literature review

    Research output: Contribution to journalReviewResearchpeer-review

  4. The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

INTRODUCTION: Hyperprolactinemia is a common side-effect of antipsychotic treatment. Antipsychotics and hyperprolactinemia are both considered risk factors of metabolic disturbances and diabetes. Investigations on prolactin response to meal ingestion in antipsychotic-treated patients are missing.

MATERIAL AND METHODS: In a case-control design, 49 antipsychotic-treated, clinically stable, non-diabetic, schizophrenia spectrum male patients were compared with 93 healthy male controls by age (33.1, SD 7.4 vs. 32.9, SD 6.6 years), body mass index (26.2, SD 4.6 vs. 26.1, SD 3.9 kg/m(2)) and waist circumference (96.4, SD 13.0 vs. 96.7, SD 11.9 cm). Serum-prolactin was measured in the morning and 90 min after ingestion of a standardized liquid meal (2268 kJ).

RESULTS: Fasting prolactin levels varied considerably, and mean fasting prolactin levels did not significantly differ between patients and controls (12.33, SD 11.58 vs. 10.06, SD 8.67 ng/ml, p = 0.623). In the controls, postprandial serum prolactin was significantly reduced (Δ -2.53, SD 9.75 ng/ml, p = 0.016). In antipsychotic-treated patients postprandial serum prolactin tended to increase (Δ 2.62, SD 10.96 ng/ml, p = 0.081). Analyses of subgroups based on the prolactinogenic liability of their antipsychotic treatment indicated 22 to 65% higher postprandial prolactin levels with high and intermediate prolactinogenic antipsychotics.

DISCUSSION: A physiological postprandial suppression of serum prolactin appears absent in antipsychotic-treated males. Marked variability in fasting prolactin levels may reflect individual variations in the diurnal cycle. Uniform acquisition procedures accounting for diurnal variation and food intake may enhance reliability of prolactin levels in antipsychotic-treated male patients.

Original languageEnglish
JournalPsychoneuroendocrinology
Volume60
Pages (from-to)1-6
Number of pages6
ISSN0306-4530
DOIs
Publication statusPublished - Oct 2015

ID: 45701318